Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride in Healthy Male Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the bioequivalence of two batches of Flomax® 0.4
mg capsules in healthy male subjects. One is a commercial scale batch produced at the Nishine
facility, and the other is a batch, of equal size, produced at the Norman II facility